Medicare Enrolled
Dr. Solomon Spiegel, D.O.
Interventional Cardiology · Denton, TX
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Spiegel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spiegel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Spiegel
Dr. Solomon Spiegel is an interventional cardiology in Denton, TX, with 13 years in practice. Based on federal Medicare data, Dr. Spiegel performed 4,646 Medicare services across 3,293 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spiegel received a total of $6,567 from 38 pharmaceutical and/or device companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spiegel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 15% volume in TX$ $6,567 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,646
Medicare services
Top 15% in TX for interventional cardiology
3,293
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~357 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 1,077 | $10 | $51 |
| Office visit, established patient (30-39 min) | 636 | $88 | $238 |
| Office visit, established patient (20-29 min) | 423 | $58 | $168 |
| Regadenoson injection (Lexiscan) for heart stress test | 376 | $38 | $206 |
| Anticoagulant management of patient taking warfarin | 365 | $8 | $41 |
| Echocardiogram, transthoracic | 220 | $140 | $722 |
| Injection, perflutren lipid microspheres, per ml | 164 | $34 | $371 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 122 | $58 | $462 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 121 | $47 | $258 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 117 | $328 | $1,599 |
| New patient office visit (45-59 min) | 114 | $107 | $310 |
| Prothrombin time test (blood clotting) | 107 | $4 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 94 | $9 | $128 |
| Office visit, established patient, complex (40-54 min) | 67 | $130 | $335 |
| Remote pacemaker monitoring, 90 days | 45 | $21 | $109 |
| Cardiac catheterization | 45 | $179 | $1,035 |
| Remote pacemaker/defibrillator monitoring, 90 days | 44 | $16 | $84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 37 | $27 | $213 |
| Hospital follow-up visit, moderate complexity | 32 | $61 | $186 |
| Telephone medical discussion with physician, 5-10 minutes | 31 | $41 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $2 | $28 |
| Ultrasound of both sides of head and neck blood flow | 29 | $140 | $704 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 29 | $74 | $431 |
| Coronary stent placement | 28 | $412 | $2,057 |
| Heart rhythm recording of continous external ekg over 8-15 days | 28 | $8 | $96 |
| Ultrasound study of arm and leg arteries | 26 | $48 | $299 |
| New patient office visit (30-44 min) | 26 | $73 | $207 |
| Initial hospital admission, moderate complexity | 25 | $100 | $352 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $70 | $333 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 22 | $14 | $36 |
| New patient office visit, complex (60-74 min) | 19 | $137 | $409 |
| Ultrasound of leg arteries or artery grafts | 18 | $177 | $891 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $149 | $841 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $81 | $425 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $14 | $65 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $5 | $155 |
| Initial hospital admission, high complexity | 14 | $133 | $517 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 13 | $61 | $1,220 |
| External shock to heart to regulate heart beat | 11 | $82 | $707 |
| Ultrasound of heart, follow-up | 11 | $63 | $361 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.9% high complexity
19.6% medium
69.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,567
Total received (2018-2024)
Avg $938/year across 7 years
Bottom 41% in TX for interventional cardiology
38
Companies
170
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,553 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$969
2023$618
2022$802
2021$551
2020$472
2019$501
2018$2,655
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$1,706
Cardiovascular Systems Inc.
$827
Abbott Laboratories
$465
AstraZeneca Pharmaceuticals LP
$439
Shockwave Medical, Inc
$297
ShockWave Medical, Inc
$294
Novartis Pharmaceuticals Corporation
$236
CVRx, Inc.
$236
Endologix LLC
$188
Philips Electronics North America Corporation
$175
BOSTON SCIENTIFIC CORPORATION
$158
ABIOMED
$125
SANOFI-AVENTIS U.S. LLC
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Alnylam Pharmaceuticals Inc.
$119
PFIZER INC.
$105
Janssen Pharmaceuticals, Inc
$105
Medtronic, Inc.
$99
DePuy Synthes Sales Inc.
$90
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$87
iRhythm Technologies, Inc.
$77
Potrero Medical, Inc.
$61
Amgen Inc.
$55
ATRICURE, INC.
$50
Astellas Pharma US Inc
$39
AtriCure, Inc.
$38
Baxter Healthcare
$36
E.R. Squibb & Sons, L.L.C.
$32
Otsuka America Pharmaceutical, Inc.
$29
HeartFlow, Inc.
$22
Cardinal Health 200, LLC
$22
Regeneron Healthcare Solutions, Inc.
$21
BIOTRONIK INC.
$21
Lexicon Pharmaceuticals, Inc.
$19
KLS-Martin L.P.
$15
Intact Vascular, Inc.
$14
MEDICOMP INC
$13
Boston Scientific Corporation
$11
Top 3 companies account for 45.7% of total payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · (6342) Intrasight Integ · (6577) Visions 014 · ABRE · AMPLATZER AMULET · ANGIOJET · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · Advisa · Asahi Fielder coronary guide wire · Azure · BRILINTA · Barostim Neo System · CAMZYOS · CONFIRM RX · CardioMEMS HF System · CoreValve Evolut · Coronary Orbital Atherectomy System · Diamondback Peripheral · ELIQUIS · ELUVIA · EMBOGUARD · ENDOCROSS Device · ENTRESTO · FARXIGA · FFRct · GENERAL VASCULAR ACCESS · HAWKONE · HawkOne · HeartMate · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · IGT Devices Und · IN.PACT Admiral · Impella · Inpefa · Integrity · JARDIANCE · JETSTREAM · LEQVIO · LEXISCAN · LifeVest · MULTAQ · ONPATTRO · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Protege RX · RESOLUTE ONYX · Repatha · Resolute · SAMSCA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Supera peripheral stent system · TELEPATCH CARDIAC MONITOR · TELESCOPE · Tack Endovascular System · Torus Stent Graft System · Tryton Side Branch Stent · VYNDAQEL · Vascular Lithotripsy · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $141 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
30
Per 100K population
3.2
County median income
$108,185
Nearest hospital
MEDICAL CITY DENTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Spiegel is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 15% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Spiegel experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Spiegel performed 1,077 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spiegel receive payments from pharmaceutical companies?
Yes. Dr. Spiegel received a total of $6,567 from 38 companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spiegel's costs compare to other interventional cardiologys in Denton?
Dr. Spiegel's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spiegel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Denton
Browse interventional cardiologys in Denton ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology